235 related articles for article (PubMed ID: 33344225)
1. Development and Validation of Nomograms Based on Gamma-Glutamyl Transpeptidase to Platelet Ratio for Hepatocellular Carcinoma Patients Reveal Novel Prognostic Value and the Ratio Is Negatively Correlated With P38MAPK Expression.
Luo D; Li H; Hu J; Zhang M; Zhang S; Wu L; Han B
Front Oncol; 2020; 10():548744. PubMed ID: 33344225
[TBL] [Abstract][Full Text] [Related]
2. Predictive nomograms based on gamma-glutamyl transpeptidase to prealbumin ratio for prognosis of hepatocellular carcinoma patients without microvascular invasion.
Ma M; Xie K; Jin T; Xu F
BMC Cancer; 2024 May; 24(1):617. PubMed ID: 38773511
[TBL] [Abstract][Full Text] [Related]
3. Development and validation of a prognostic model based on the albumin-to-fibrinogen ratio (AFR) and gamma-glutamyl transpeptidase-to-platelet ratio (GPR) in hepatocellular carcinoma patients.
Zhang J; Wang T; Xu L; Wang P; Zhang M; Xu M
Clin Chim Acta; 2020 Dec; 511():107-116. PubMed ID: 33035501
[TBL] [Abstract][Full Text] [Related]
4. Novel Nomogram Based on Inflammatory Markers for the Preoperative Prediction of Microvascular Invasion in Solitary Primary Hepatocellular Carcinoma.
Gu Y; Zheng F; Zhang Y; Qiao S
Cancer Manag Res; 2022; 14():895-907. PubMed ID: 35256861
[TBL] [Abstract][Full Text] [Related]
5. Development and Validation of a Prognostic Nomogram in AFP-negative hepatocellular carcinoma.
Wang X; Mao M; He Z; Zhang L; Li H; Lin J; He Y; Dai S; Hu W; Liu W
Int J Biol Sci; 2019; 15(1):221-228. PubMed ID: 30662361
[TBL] [Abstract][Full Text] [Related]
6. Inflammation-related nomogram for predicting survival of patients with unresectable hepatocellular carcinoma received conversion therapy.
Wu JL; Luo JY; Jiang ZB; Huang SB; Chen GR; Ran HY; Liang QY; Huang MS; Lai LS; Chen JW
World J Gastroenterol; 2023 May; 29(20):3168-3184. PubMed ID: 37346152
[TBL] [Abstract][Full Text] [Related]
7. γ-glutamyl transferase-to-platelet ratio based nomogram predicting overall survival of gallbladder carcinoma.
Sun LJ; Guan A; Xu WY; Liu MX; Yin HH; Jin B; Xu G; Xie FH; Xu HF; Du SD; Xu YY; Zhao HT; Lu X; Sang XT; Yang HY; Mao YL
World J Gastrointest Oncol; 2020 Sep; 12(9):1014-1030. PubMed ID: 33005295
[TBL] [Abstract][Full Text] [Related]
8. Novel inflammation-based prognostic nomograms for individualized prediction in hepatocellular carcinoma after radical resection.
Zeng J; Zeng J; Wu Q; Lin K; Zeng J; Guo P; Zhou W; Liu J
Ann Transl Med; 2020 Sep; 8(17):1061. PubMed ID: 33145280
[TBL] [Abstract][Full Text] [Related]
9. Novel Nomograms Based on Gamma-Glutamyl Transpeptidase-to-Lymphocyte Ratio Predict Prognosis of Hepatocellular Carcinoma Patients After Hepatectomy.
Ma C; Cao Y; Zhang G; Qiu J; Zhou Y; Wang P; Wang S; Yan D; Ma D; Jiang C; Wang Z
J Hepatocell Carcinoma; 2023; 10():217-230. PubMed ID: 36798739
[TBL] [Abstract][Full Text] [Related]
10. Predictive potential of Nomogram based on GMWG for patients with hepatocellular carcinoma after radical resection.
Ren L; Chen D; Xu W; Xu T; Wei R; Suo L; Huang Y; Chen H; Liao W
BMC Cancer; 2021 Jul; 21(1):817. PubMed ID: 34266388
[TBL] [Abstract][Full Text] [Related]
11. Novel Prognostic Nomograms Based on Inflammation-Related Markers for Patients with Hepatocellular Carcinoma Underwent Hepatectomy.
Wang Y; Sun K; Shen J; Li B; Kuang M; Cao Q; Peng S
Cancer Res Treat; 2019 Oct; 51(4):1464-1478. PubMed ID: 30913869
[TBL] [Abstract][Full Text] [Related]
12. A new model based on gamma-glutamyl transpeptidase to platelet ratio (GPR) predicts prognostic outcome after curative resection of solitary hepatocellular carcinoma.
Yang D; Wu H; Nong W; Zheng M; Li A; Wang Y; Li M; Chen Q; Yuan S; Yu J; Liao W
Clin Res Hepatol Gastroenterol; 2021 Sep; 45(5):101509. PubMed ID: 33744828
[TBL] [Abstract][Full Text] [Related]
13. A Novel Nomogram Based on Hepatic and Coagulation Function for Evaluating Outcomes of Intrahepatic Cholangiocarcinoma After Curative Hepatectomy: A Multi-Center Study of 653 Patients.
Cai Y; Zhang B; Li J; Li H; Liu H; Xie K; Du C; Wu H
Front Oncol; 2021; 11():711061. PubMed ID: 34322394
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of combined preoperative gamma-glutamyl transpeptidase to platelet ratio and fibrinogen in patients with HBV-related hepatocellular carcinoma after hepatectomy.
Dai T; Deng M; Ye L; Liu R; Lin G; Chen X; Li H; Liu W; Yang Y; Chen G; Wang G
Am J Transl Res; 2020; 12(6):2984-2997. PubMed ID: 32655824
[TBL] [Abstract][Full Text] [Related]
15. Screening of Hepatocellular Carcinoma Patients with High Risk of Early Recurrence After Radical Hepatectomy Using a Nomogram Model Based on the γ-Glutamyl Transpeptidase-to-Albumin Ratio.
Pang S; Shi Y; Xu D; Sun Z; Chen Y; Yang Y; Zhao X; Si-Ma H; Yang N
J Gastrointest Surg; 2022 Aug; 26(8):1-9. PubMed ID: 35508683
[TBL] [Abstract][Full Text] [Related]
16. The Age, Gamma-Glutamyl Transpeptidase and Platelet Index: A Novel Noninvasive Model for Predicting Hepatocellular Carcinoma in Patients with Hepatitis B Virus-Related Liver Cirrhosis.
Liu K; Huang Z; Yang S; Lin L; Zheng S; Zhang X; Xue Y; Xie W
J Hepatocell Carcinoma; 2022; 9():1057-1063. PubMed ID: 36250136
[TBL] [Abstract][Full Text] [Related]
17. A Novel Nomogram Model to Predict the Recurrence-Free Survival and Overall Survival of Hepatocellular Carcinoma.
Zhang SW; Zhang NN; Zhu WW; Liu T; Lv JY; Jiang WT; Zhang YM; Song TQ; Zhang L; Xie Y; Zhou YH; Lu W
Front Oncol; 2022; 12():946531. PubMed ID: 35936698
[TBL] [Abstract][Full Text] [Related]
18. Combined preoperative albumin-bilirubin (ALBI) and serum γ-glutamyl transpeptidase (GGT) predicts the outcome of hepatocellular carcinoma patients following hepatic resection.
Zhang CH; Ni XC; Chen BY; Qiu SJ; Zhu YM; Luo M
J Cancer; 2019; 10(20):4836-4845. PubMed ID: 31598154
[No Abstract] [Full Text] [Related]
19. Development and validation of prognostic nomograms in patients with hepatocellular carcinoma: a population-based study.
Zang Y; Long P; Wang M; Huang S; Chen C
Future Oncol; 2021 Dec; 17(36):5053-5066. PubMed ID: 34676798
[No Abstract] [Full Text] [Related]
20. A novel nomogram to predict the overall survival of early-stage hepatocellular carcinoma patients following ablation therapy.
Zhang H; Sheng S; Qiao W; Han M; Jin R
Front Oncol; 2024; 14():1340286. PubMed ID: 38384805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
